Dansk
Handbook of Biogeneric Therapeutic Proteins e-bog
509,93 DKK
(inkl. moms 637,41 DKK)
More than 20 billion dollars worth of biopharmaceuticals are scheduled to go off-patent by 2006. Given the strong political impetus and the development of technological tools that can answer the questions regulatory authorities may raise, it is inevitable that the FDA and EMEA will allow biogeneric or biosimilar products. Even with all the regulato
E-bog
509,93 DKK
Forlag
CRC Press
Udgivet
15 august 2002
Længde
584 sider
Genrer
MMG
Sprog
English
Format
pdf
Beskyttelse
LCP
ISBN
9781420037937
More than 20 billion dollars worth of biopharmaceuticals are scheduled to go off-patent by 2006. Given the strong political impetus and the development of technological tools that can answer the questions regulatory authorities may raise, it is inevitable that the FDA and EMEA will allow biogeneric or biosimilar products. Even with all the regulato